IE60098B1 - Binding-inducing composition - Google Patents
Binding-inducing compositionInfo
- Publication number
- IE60098B1 IE60098B1 IE86488A IE86488A IE60098B1 IE 60098 B1 IE60098 B1 IE 60098B1 IE 86488 A IE86488 A IE 86488A IE 86488 A IE86488 A IE 86488A IE 60098 B1 IE60098 B1 IE 60098B1
- Authority
- IE
- Ireland
- Prior art keywords
- composition
- tooth
- teeth
- enamel
- enamel matrix
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 48
- 230000001939 inductive effect Effects 0.000 title claims description 8
- 210000003298 dental enamel Anatomy 0.000 claims description 41
- 239000011159 matrix material Substances 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 22
- 201000001245 periodontitis Diseases 0.000 claims description 16
- 239000002243 precursor Substances 0.000 claims description 7
- 241000283690 Bos taurus Species 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 210000001080 enamel organ Anatomy 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 210000000246 tooth germ Anatomy 0.000 claims description 3
- 244000052616 bacterial pathogen Species 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- 238000007790 scraping Methods 0.000 claims 1
- 230000003239 periodontal effect Effects 0.000 description 28
- 230000035876 healing Effects 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 20
- 210000004379 membrane Anatomy 0.000 description 18
- 239000012528 membrane Substances 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- 241000282693 Cercopithecidae Species 0.000 description 13
- 238000001356 surgical procedure Methods 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000000981 epithelium Anatomy 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 210000004268 dentin Anatomy 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 4
- 108010049003 Fibrinogen Proteins 0.000 description 4
- 102000008946 Fibrinogen Human genes 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000282887 Suidae Species 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 229940012952 fibrinogen Drugs 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- 239000003106 tissue adhesive Substances 0.000 description 4
- 108010071289 Factor XIII Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 229940012444 factor xiii Drugs 0.000 description 3
- 210000004195 gingiva Anatomy 0.000 description 3
- 229940033618 tisseel Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010039627 Aprotinin Proteins 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229960004405 aprotinin Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- -1 aprotlnin Proteins 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000001750 dental cementum Anatomy 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000004416 odontoblast Anatomy 0.000 description 1
- 210000004261 periodontium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
Description
NETHERLANDS ANTILLES, OF DE RUYTERKADE 58A, CURACAO, NETHERLANDS ANTILLES.
(72) Inventor
LARS HAMMARSTROM SVEN LINDSKOG LEIF BLOMLOF (C) Copyright 1994, Government of Ireland.
t6C098
Binding-inducing composition
The present invention relates to a composition for uae ; in inducing binding between parte of living mineralized tissue by new formation of mineralized tissue on at least one of * the parts but possibly also on the other part. The invention also relates to a process for inducing such binding, for example for ths treatment of periodontitis.
The present invention relates to new biologically based techniques useful with regard to inducing binding between parts of mineralized tissue, for example bone. Even if the invention is generally applicable to provide for such binding it will, in the present disclosure, be illustrated mainly in connection with the treatment of loosening teeth, so called periodontitis, However, it should be noted that thie principal illustration of the invention must not be interpreted in a limiting manner. Before the techniques of the invention are described more closely it is suitable, in order to facilitate understanding of the invention, to give a brief background to the biological conditions in connection with teeth and associated disorders. At normal dental statue the teeth are anchored in special cavities, so called alveoli, in the jaw bone, Between the roots of the teeth and the jaw bone a so called periodontal membrane is located. The roots of the teeth are mainly eonetituted by a material called dentin. This dentin is peripherally covered by a thin layer of cementum, thickness about 0.01 to 1 mm. In this cementum inter alia collagen fibres are found which extend from the cementum through the periodontal membrane and which are anchored in the jaw bone. Thus, the cementum is extremely ’ important for the attachment of a tooth to the jaw bone. The periodontal membrane has a thickness of about 0.2 mm and consists of the above-mentioned collagen fibres and vessels and nervee lying between eaid fibres and cells belonging to these tissues.
The jaw bone doss not extend all the way up to the crown of the tooth, and in the part of the root which ie not covered by jaw bone fibres from the root cementum extend out into the surrounding tooth gum, the gingiva. These fibres assist in anchoring the tooth and, furthermore, stabilize the tooth gum. The tooth gum, as well as the whole oral cavity, is covered by a thin layer of epithelium. This epithelium forms a dense collar or sleeve around the teeth. Adjacent to the teeth there is formed a shallow furrow between the teeth and the epithelium.
Inflammatory disorders in the tissues attaching the teeth to the jaw bone are quite frequent and strike to a varying extend the major part of the population all over the world. The methods of treatment hitherto used are mainly aiming at retarding an ongoing disease process and at preventing loosening of the teeth as far as possible. Presently, no clinically applicable method exists having the ability of providing healing in such a manner as to enable the teeth to regain attachment to the jaw bone.
A partial problem within this area ie the cases where the patients have a congenital defect in the dental attachment. Such patients develop symptoms of periodontitis at an early age, so called juvenil periodontitis. The treatment often involves extraction of the tooth and replacement with some bridge construction at a substantial cost.
The bacteria on the surface of the teeth cause cronic inflammation in the tooth gum around the teeth. Inflammatory cells excrete their decomposing enzymes which are intended for the bacteria, but in this case they attack the collagen fibres attaching the tooth to gingiva and jaw bone. The cells on the surface of the tooth root or the cementum are subject to destruction and epithelium from the oral mucous membrane grows downwardly along the teeth and produces a so called gingival crevice. In this crevice new bacteria obtain a protected area where they can grow. New inflammatory cells are collecting in said area, and the decomposition of the tissues of the periodontal membrane proceeds. The cementum cells sue3 cumb and the bone of the alveolar area ie destroyed. The process proceeds generally very slowly but can at intervale proceed very fast. After some time the teeth subject to attack will completely lose their attachment to the jaw bone. .
Today's treatment ie principally directed at removing the bacterial deposits on the tooth surfaces. When the bac- * teria are removed the inflammation in the gingiva and the periodontal membrane ceases and the decomposition process comes to a stop. The treatment also aims to preventing new bacterial deposits to form on the dental surface, Thus, the treatment results in ending the destruction of the attachment of the teeth to the jaw bone, but no new periodontal membrane or new cementum will be formed in the healing.
In connection with the research forming the basis of the present invention it has now somewhat surprisingly been found that the formation of cementum is initiated by a thin layer of a precursor to enamel which, in development of the root is formed along all of the root surface. This layer of enamel seems to affect collagen fibre cells in the area so that they develop to cells forming cementum. The thin layer of enamel seems to disappear to a great extent in the continued development of the cementum, but in certain areas remaining residues can be observed.
In connection with investigations made, it has been found that if dentin is exposed to the cells of the periodontal membrane, for example by grinding a cavity in the surface of the root, healing takes piece in the form of a bone-like tissue i.a. lacking the fibres attaching the tooth to the surrounding tissues. If, however, the generated eavity is covered with a precursor to enamel, in the following called enamel matrix, it is found that normal cementum tissue is generated. In the introductory experiments endogenous enamel matrix was used, but it was later found that the same favourable results were obtained using enamel matrix from a totally different animal species. Thue, it has been found in experiments on monkeys that one can induce formation of ce4 mentum by covering a cavity ground in the surface of the root with enamel matrix of, for example porcine origin.
By the following invention there ie thus provided new techniques for inducing binding between parts of living mine5 ralized tissue by renewed formation of mineralized tissue on at leaet one of the parte, and theee techniques are characterized by the application of a precursor to enamel, so called enamel matrix for ths induction of binding. Thus, the invention provides a composition for such use and said compos it ion contains as an active constituent such enamel matrix.
As previously indicated the invention is particularly applicable in connection with dental therapies, for example for the treatment of periodontitie, i.e. loosening of teeth, in transplantation of teeth or in reintroduction of teeth disconnected by accident. However, the invention can be used also to facilitate healing of artificial implantes, for example tooth implantes, implantes of skeletal replacements such as artificial hip joints. The invention may also be used to induce formation of mineralized tissue on such skeletal replacements where it is desired to provide for a new tendon attachment. The enamel matrix used in applying the techniques according to the present Invention is suitably obtained from some mammal the teeth of which are under development. A suitable source of the enamel matrix is slaughtered animals, for example pigs or calves, the sacrifice of which often takes place while the teeth still are under development, in the case of pigs for slaughter an age of about half a year. Preferred mammals ere thus selected from bovine or porcine species (i.e. cattle or pig) but also other species are conceivable, for example sheep and rodents which have continuously growing teeth. As an alternative source of this substance one may also use cultivated cells or bacteria (recombinant DNA-technique).
The composition according to the invention may consist of only such enamel matrix, suitably admixed with water, but the composition may also contain the enamel matrix in combi5 nation with & carrier, diluent or adhesive acceptable for the purpose. For dental use it ie suitable that the carrier or diluent is dentally acceptable. The composition may optionally contain stabilizers or preserving agents for the purpose of increasing storage etability. Solely the dental matrix in < combination with water can, however, be stored in the cold for a certain period of time up to the actual uee. *
The invention provides a process for the treatment of periodontitis involving regaining attachment of the teeth by inducing a formation of root cementum and jaw bone and a physiological collagen fibre attachment between these. The process is characterized in that epithelium, if present, is removed from the root of the tooth and the root ie then supplied with a layer of precursor to dental enamel, so called enamel matrix.
Jn the preferred application of the invention for the treatment of periodontitis the area of a tooth subject to attack is subjected to incision to expose the surface of the root while removing possibly formed epithelium, the clean surface of the root is then coated with a layer of enamel matrix or a composition containing such enamel matrix ae an active constituent, after which the collagen tissue ie repositioned and optionally stitched eo that healing can take place .
As previously mentioned the invention can be used, in addition to the treatment of periodontitis, in replantation or transplantation of teeth. It is relatively frequent that youths in their lower teenage are subject to accidents which result in dislocation of one or several teeth. This is mainly the case with the front teeth. By quickly putting back the dislocated teeth good healing can be obtained with normal
A attachment to the jaw bone. In many cases such reinstatement of dislocated teeth cannot be carried out within a reasonable a
period of time, but the teeth muet be kept for a period of time in an unsuitable medium outside the mouth, for example in the free air. The celle of the periodontal membrane on the surface of the root β
will then have been destroyed, and when the tooth is put back in location in the mouth it will not regain a physiological attachment but fall out after a certain period of time. Up to now no method has been deviced by which one can obtain
S regeneration of a new attachment.
In accordance with the techniques of the invention the dead periodontal membrane on the dislocated tooth may, however, be removed in a suitable manner, which can be mechanical or chemical, and the composition of enamel matrix is then applied to the naked surface of the root. The tooth is then put back into its alveolus and lightly fixed for some weeks. Due to the new enamel matrix on the surface of the root a new cementum layer will be generated and the tooth will hereby obtain new attachment.
Zn regard to the transplantation of teeth, i.e. transfer of teeth from one individual to another, it has been found that the tissues of transplanted teeth are attacked by the immune defense of the receiver and decomposed in a very short period of time. Attempts have been made to carry out transplantation between immunologically suitable individuals.
Also these attempts have, however, been discouraging. Neither has it been considered reasonable to resort to long term treatment with pharmacological preparations suppressing the rejection reaction for the purpose of maintaining one or several transplanted teeth. Thus, there is today no clinioally useful method for transplantation of teeth leading to a favourable long term prognosis.
However, by employing the techniques according to the present invention the problem can be solved by removing the teeth to be transplanted from the donor, removing the dental pulp, cleaning the pulp epace and applying the root filler agent in the pulp space. The periodontal membrane is mechanically or chemically removed and the root of the tooth is covered with the composition containing enamel matrix. Then th<
tooth is placed in its new location in the receiver's mouth.
The tooth is maintained in a fixed position for a short peri od of time, and due to the enamel matrix, reformation of endogeneoue mineralized tissue which covers the transplanted tooth and provides fixation of same will be induced.
According to a further preferred aspect of this invention the enamel matrix composition may be supplemented with a tissue adhesive based on fibrinogen, Faetor XIII (which is a * plasma-derived coagulation factor) and thrombin. Such supplemented composition may be constituted by a premix of enamel matrix and fibrinogen and Factor XIII, the thrombin being added immediately before applying the composition to ths surgical site. The premix may optionally contain aprotinin to reduce the rate of decomposition. A preferred commercial product for use in such supplemented composition is Tisseel® , a two-component fibrin sealant manufactured and sold by IMMUNO AG, Vienna, Austria.
In using such tissue adhesive the premix of enamel matrix, fibrinogen, Factor XIII and, optionally, aprotinin, is mixed with a thrombin solution, and the resulting composition is then rapidly applied to the surgical site. In the treatment of periodontitis thie technique greatly facilitates surgery. Thus, the adhesion of the composition to the root ie enhanced, bleeding is stopped and positioning of the mueo-periosteal flap is greatly simplified while eliminating the use of Buturee.
The invention will in the following be further illustrated in conjunction with specific examples. The exemplification is made in connection with dental experiments performed on rats, monkeys and humans. The exemplification is made in connection with the appended drawing, wherein.
Fig. 1 shows a detail of a cross section through a root of a tooth with adjoining tissues from a monkey;
Fig. 2 shows a detail of a cross section of the root of a tooth from a monkey treated in accordance with the invention;
Fig. 3 shows a detail of a replanted monkey tooth without treatment;
Fig. 4 shows a corresponding detail but on a tooth θ
treated in accordance with the invention;
Fig. 5 ehowe an intra-oral radiograph taken before surgery; and
Fig. 6 shows a corresponding radiograph taken after surgery.
The detail blowup shown in Fig. 1 illustrates a cross section through a root of a tooth with adjoining tissues from a monkey tooth which is normally and naturally attached to the jaw bone. Between jaw bone 1, wherein the teeth are at10 tached, and root 7 of the tooth, the dentin, the so called cementum 3 and the periodontal membrane 5 providing fixation of the tooth to the jaw bone 1 are found adjacent to root 7 of the tooth.
IS EXAMEidsUs.
In the following examples there is used ae a treating composition a precursor to enamel, i.e. enamel precursor or enamel matrix, tissue obtained from pigs for slaughter sacrificed at an age of about 6 months and thus provided with teeth under development. From cleaned pig jaws the tooth germs are isolated. These germs are constituted by enamel matrix producing cells (the enamel organ), enamel matrix, dentin, odontoblasts and dental papille. The tooth germs freed of the enamel organ are scraped to ieolate and recover the desired enamel matrix, a semi-solid white mass being obtained which is homogenized with water to form a whipped cream-like consistency. The homogenizer used is a ao called polytron manufactured by Kinematics GmbH, Luzern,
Switzerland. The composition obtained is then used in the following examples,
BXAMEULJ
A tooth is extracted from a monkey and is then stored in air for one hour, the periodontal membrane being then re35 moved. On the root of the tooth there is then applied a thin layer of enamel matrix from pig manufactured ae above, the tooth being then repositioned in its location in the jaw bone .
In Fig. 2 there is shown how after a few weeks a new periodontal membrane 5 hae been regenerated between jaw bone . 1 and root 7 of the tooth, and also a new eementum layer 3 has been iormed between the periodontal membrane 5 and the * root 7 of the tooth. Due to the use of the composition according to the present invention the replantation of the monkey tooth has thus been carried out successfully with complete renewed anchorage of the tooth in the jaw bone.
EXAMPLE 2
This example is a comparison between healing of a cavity ground in a monkey tooth with and without treatment while using the techniques according to the present invention. In Fig. 3 there ie shown a detail blowup of the area between jaw bone 1 and root 7 of a monkey tooth. This tooth has been first extracted , then a cavity hae been ground on the eurface of the root and the tooth has then been put back in its location in the jaw bone for healing. The enlargement according to Fig. 3 shows the healing after 8 weeks, and as is eeen only small areas of bone-like mineralized tissue have been formed (see the curved arrows).
In Fig. 4 there is shown an experiment carried out in the same manner but whore the generated cavity has been filled with the composition prepared according to tha above before putting back the tooth. Also here the healing after 6 weeks is shown, and it is clear from the figure how well the periodontal membrane 5 hae healed. The figure also shows how new eementum 3 has been formed in the cavity (cf. the non-filled arrows).
EXAMPLE-J
The purpose of this example ie to show the influence of the attachment-promoting composition on healing of experimental marginal periodontal wounds. Experimental defects in the marginal periodontium of monkey teeth were created by removing dental cementum, periodontal membrane and marginal alveolar bone to a cervico-apical distance of approximately
5mm with a dental bur. The composition was then applied to the experimental defects and the area allowed to heal. Control defect· were also prepared but allowed to heal without the application of the composition. After a healing period the result· were evaluated histologically.
The results ehow that healing, in a way similar to the 10 results described in the previous examples was obtained only when the composition had been applied. This comprised the formation of an adhering layer of new cementum, periodontal membrane and alveolar bone. Thus, new attachment had resulted. This was not the case for the control teeth where the defect persisted only to have been covered with oral epithelium. These results indicate an application of the composition in the treatment of periodontitis.
EXAMPLE Λ
This example shows the influence of “the attachmentpromoting composition11 on marginal periodontal healing following treatment of periodontitis in an experimental animal. Monkeys with naturally occuring periodontitis were selected for the experiment. They recieved conventional periodontal surgery after which one experimental side in each animal wae treated with application of the composition on the exposed root surfaces. The other side served ae a control. After a healing period the results were evaluated hietomorphometrically.
«30 The results showed that, after application of the composition a new marginal attachment had been created, coneie* ting of new adhering cementum, periodontal membrane and alveolar bone up to a level corresponding to the enamel-cementum border. In figures this moans several millimeters of new periodontal attachment. The control teeth only showed insignificant and inconsistent gain of new attachment without any new cementum. These results indicate an application for the composition in the treatment of periodontitis also in man.
e
EXAMPLE &
The purpose of this example ie to show the influence of ' the attachment-promoting composition on marginal periodontitis in man. After approval from The Swedish Medieal Board and The Regional Bthiee Comittee the composition was used as an adjunct to conventional surgical treatment of patients with marginal periodontitis. The patients were operated during which dental calculus and granulation tissue were removed. The composition was painted on the naked root surfaces and covered with a muco-periostal flap. The healing results were evaluated by periodical clinical inspection, recording of pocket depth and ingival index ae well as examination of intra-oral radiographs. The results after application of the composition was compared with previous quantitative studies on conventional periodontal surgery.
The results showed that the composition had promoted a significant increase of marginal alveolar bone height (Pigs.
and 6). These figures show intra-oral radiographs taken before (Pig. 5) and 6 months after (Pig. 6) periodontal surgery involving the application of “the attachment-promoting composition*'. The pre-operative radiograph (Pig. 5) shows that the level (arrow) of the alveolar bone (i> is situated almost at the apex of the tooth. Six months after the application of the composition (Pig. 6> a significant amount of new alveolar bone (1) has been formed and the level is indicated by an arrow at mid-root and ie raised by several millimeters. Such a healing result has never been seen after conventional periodontal surgery. Healing in general appeared to
Λ progress more rapidly both regarding clinical appearance and reduction of marginal pocket depths compared with previous studies on conventional periodontal surgery. These results show that the compoeition also has the ability to promote new periodontal attachment in man, a healing result not seen with conventional treatments.
EXAMPLE. 6 ' This example illustrates an improved method of applica5 tion of the attachment-promoting composition in clinical ' practice. Patients with marginal periodontitis were treated ae described in Example 5 with the only difference that a fibrin-based tissue adhesive was mixed in with the composition. The tieeue adhesive is composed of fibrinogen, plasma10 fibronectin, Factor XIII (a plasma-derived coagulation factor), plasminogen, aprotlnin, thrombin and calcium chloride and manufactured by IMMUNO AG, Vienna, Austria. The tissue adhesive marketed under the name of Tisseel or Tiesucol polymerizes after its various components have been mixed together ίδ to form an adhering coagulum. Thus, the addition of Tisseel (Tiesucol) to the attachment-promoting composition enhances adhesion to the root surfaces during periodontal surgery. Furthermore, bleeding ie stopped, facilitating visibility and positioning or the muco-perioeteal flap. The flap can also be positioned more cervically on the root surfaces and sutures can be eliminated. Covering the root surfaces is essential for the healing results einc* thie ultimately determines the degree of new attachment.
EXAMPLE 7
The purpose of thie example ie to describe the mineralized tissue-inductive capacity of the attachment-promoting composition. The composition was placed in gelatin capsules which were operated into the abdominal muscle in rata. Sham operated rats were used as control. After a healing period the rats were killed and the tissue reaction in the operated areas was evaluated with radiographs, histology end incorporation of ^®Ca.
The results showed that a mineralized tieeue, resemb35 ling cementum had been formed following the application of the composition. No traces of any newly formed tieeue were seen in the sham operated animals.
The experiments presented above show unambiguously the practical application and advantages of the present invention. In view of the fact that enamel matrix from pig has been used in experiments performed on monkeys the tests addi tionally show that it is not necessary to use an endogenous enamel matrix. This latter finding is, of course, a substantial advantage since it means that easy access to raw material can be ensured.
Claims (7)
1. A composition for use in inducing binding between parts of living mineralized tissue by regeneration of mineralized tissue on at least one of the parts, characterized in that it contains as an active constituent 5 a precursor to dental enamel, so called enamel matrix.
2. A composition according to claim 1 for use in treating periodontitis.
3. A composition according to claim 2 for human use. 10
4. A composition according to any preceding claim, characterized in that the enamel matrix originates from a mammal.
5. A composition according to claim 4, characterized in that the enamel matrix originates from a 15 bovine or porcine species.
6. A composition according to any preceding claim, comprising said enamel matrix in combination with a dentally or biologically acceptable carrier, diluent or adhesive. 20
7. A method for preparing the composition of any one of claims 1 to 6 comprising isolating tooth germs freed of enamel organ and scraping said germs to isolate and recover the desired enamel matrix.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE86488A IE60098B1 (en) | 1988-03-23 | 1988-03-23 | Binding-inducing composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE86488A IE60098B1 (en) | 1988-03-23 | 1988-03-23 | Binding-inducing composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE880864L IE880864L (en) | 1989-09-23 |
| IE60098B1 true IE60098B1 (en) | 1994-06-01 |
Family
ID=11019102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE86488A IE60098B1 (en) | 1988-03-23 | 1988-03-23 | Binding-inducing composition |
Country Status (1)
| Country | Link |
|---|---|
| IE (1) | IE60098B1 (en) |
-
1988
- 1988-03-23 IE IE86488A patent/IE60098B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE880864L (en) | 1989-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0263086B1 (en) | Binding-inducing composition | |
| JP2795667B2 (en) | Compositions that induce binding | |
| US5366507A (en) | Method for use in bone tissue regeneration | |
| Landsberg et al. | Clinical and Biologic Observations of Demineralized Freeze-Dried Bone Allografts in Augmentation Procedures Around Dental Implants. | |
| Bang et al. | Allogenic demineralized dentin implants in jaw defects of Java monkeys | |
| EP0333947B1 (en) | Compositions inducing binding between parts of living mineralized tissue | |
| IE60098B1 (en) | Binding-inducing composition | |
| JP3668048B2 (en) | Periodontal disease treatment material | |
| Ellender et al. | Osteogenic capacity of collagen in repair of established periodontal defects | |
| CZ193588A3 (en) | Preparation for regeneration of mineralized tissue and process for preparing thereof | |
| RU2836321C1 (en) | Method for simultaneous elimination of gingival recession and replacement of volume of lost bone tissue of alveolar process in area of gingival recession | |
| JP4836318B2 (en) | Artificial dental root with periodontal ligament formation ability | |
| PL154615B1 (en) | Method for manufacturing a enamel matrix | |
| Ramselaar et al. | Porous root replacements: reactions of the surrounding tissues | |
| WO2004098540A1 (en) | Material for treating paradental diseases | |
| PT87078B (en) | PREPARATION PROCESS FOR COMPOSITIONS FOR CONNECTING MINERALIZED FABRICS AND PROCESS FOR INDUCING THAT CONNECTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |